Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session Portfolio News / By Libby Nunan Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session Read More »
Kimia Therapeutics Appoints Imran S. Haque, Ph.D. as Chief Technology Officer Portfolio News / By Libby Nunan Kimia Therapeutics Appoints Imran S. Haque, Ph.D. as Chief Technology Officer Read More »